These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7005917)

  • 21. Ocular complications of PUVA therapy.
    See JA; Weller P
    Australas J Dermatol; 1993; 34(1):1-4. PubMed ID: 8240180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histologic alterations of psoralen- and longwave ultraviolet radiation-exposed skin.
    Harrist TJ; Gonzalez E
    Natl Cancer Inst Monogr; 1984 Dec; 66():197-204. PubMed ID: 6531029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lenticular psoralen photoproducts and cataracts of a PUVA-treated psoriatic patient.
    Woo TY; Wong RC; Wong JM; Anderson TF; Lerman S
    Arch Dermatol; 1985 Oct; 121(10):1307-8. PubMed ID: 4037825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trimethylpsoralen bath plus ultraviolet A combined with oral retinoid (etretinate) in the treatment of severe psoriasis.
    Väätäinen N; Hollmen A; Fräki JE
    J Am Acad Dermatol; 1985 Jan; 12(1 Pt 1):52-5. PubMed ID: 3980803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psoralens and ocular effects in humans.
    Glew WB; Nigra TP
    Natl Cancer Inst Monogr; 1984 Dec; 66():235-9. PubMed ID: 6531036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of PUVA in the treatment of psoriasis. Photobiology issues related to skin cancer incidence.
    Gasparro FP
    Am J Clin Dermatol; 2000; 1(6):337-48. PubMed ID: 11702610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psoralen photochemistry and nucleic acid structure.
    Hearst JE
    J Invest Dermatol; 1981 Jul; 77(1):39-44. PubMed ID: 7252256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Photochemotherapy (PUVA)].
    de la Brassinne M; Cornet F
    Rev Med Liege; 1979 Jan; 34(2):55-60. PubMed ID: 419342
    [No Abstract]   [Full Text] [Related]  

  • 29. A possible mechanism of psoralen phototoxicity not involving direct interaction with DNA.
    Laskin JD; Lee E; Yurkow EJ; Laskin DL; Gallo MA
    Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6158-62. PubMed ID: 3862124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA damage in human skin fibroblasts exposed to UVA light used in clinical PUVA treatment.
    Bredberg A
    J Invest Dermatol; 1981 Jun; 76(6):449-51. PubMed ID: 7240791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The active compounds derived from Psoralea corylifolia for photochemotherapy against psoriasis-like lesions: The relationship between structure and percutaneous absorption.
    Alalaiwe A; Hung CF; Leu YL; Tahara K; Chen HH; Hu KY; Fang JY
    Eur J Pharm Sci; 2018 Nov; 124():114-126. PubMed ID: 30153523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histological features of PUVA-induced bullae in psoriatic skin.
    McGibbon DH; Vella Briffa D
    Clin Exp Dermatol; 1978 Dec; 3(4):371-5. PubMed ID: 737881
    [No Abstract]   [Full Text] [Related]  

  • 33. Skin cancer in patients treated with 8-methoxypsoralen plus longwave ultraviolet radiation.
    Halprin KM; Comerford M; Taylor JR
    Natl Cancer Inst Monogr; 1984 Dec; 66():185-9. PubMed ID: 6531027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psoralen photoinactivation of herpes simplex virus: monoadduct and cross-link repair by xeroderma pigmentosum and Fanconi's anemia cells.
    Fendrick JL; Hallick LM
    J Invest Dermatol; 1984 Jul; 83(1 Suppl):96s-101s. PubMed ID: 6330231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of skin tumors in psoralen- and ultraviolet A-treated patients.
    Henseler T; Christophers E
    Natl Cancer Inst Monogr; 1984 Dec; 66():217-9. PubMed ID: 6531033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trioxsalen baths plus UV-A in the treatment of lichen planus and urticaria pigmentosa.
    Väätäinen N; Hannuksela M; Karvonen J
    Clin Exp Dermatol; 1981 Mar; 6(2):133-8. PubMed ID: 7261467
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits?
    Lindelöf B
    Drug Saf; 1999 Apr; 20(4):289-97. PubMed ID: 10230579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photochemical production of psoralen - DNA monoadducts capable of subsequent photocrosslinking.
    Chatterjee PK; Cantor CR
    Nucleic Acids Res; 1978 Oct; 5(10):3619-33. PubMed ID: 724496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eye protection in psoralen photochemotherapy.
    Davey JB; Diffey BL; Miller JA
    Br J Dermatol; 1981 Mar; 104(3):295-300. PubMed ID: 7213563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylangelicins: new potential agents for the photochemotherapy of psoriasis. Structure-activity study on the dark and photochemical interactions with DNA.
    Dall'Acqua F; Vedaldi D; Guiotto A; Rodighiero P; Carlassare F; Baccichetti F; Bordin F
    J Med Chem; 1981 Jul; 24(7):806-11. PubMed ID: 7277384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.